Here's an example of what's due today

Viral vector chart

Fri, Nov 6, 2026 · Week 11 · Genetics of Disease (Medical Interventions)

Today's goal: Chart how viral vectors deliver a therapeutic gene and distinguish somatic from germline targets.

Learn first

What a finished product looks like

This is a model of the work you should turn in today. Use it to check your own: match the structure and the level of detail, do not copy it. Your data and wording should be your own.

Viral vector delivery chart
Completes: Completes the vector notebook page: a labeled viral-vector delivery diagram, a somatic-versus-germline distinction, a two-vector comparison row, and a sentence on vector-cell targeting.

Diagram in words: A viral vector is a virus that has had its disease-causing genes removed and a therapeutic gene loaded in their place. It keeps its ability to enter a cell, so it delivers the healthy gene like a courier delivering a package.

Somatic vs. germline: In this case the vector targets liver cells, which are somatic (non-reproductive), so the edit is not heritable. A germline target (egg, sperm, embryo) would be heritable, which is why somatic delivery is the safer, standard choice.

Why vector choice affects which cells are treated: Different vectors prefer different tissues and have different payload sizes, so the vector you pick determines which cells receive the gene and how safely.

VectorPayload capacityIntegrates?Immune response
AAVsmallnon-integratinglow
Retroviruslargerintegrates into genomehigher insertion risk
Two-vector comparison: AAV has small capacity, does not integrate, low immune response; retrovirus has larger capacity, integrates, higher insertion-mutation risk.

Also due today: Submit your vector chart to the course shell.

Check yourself

WebXam problem for today's skill

One exam-style question that uses exactly what you practiced today. Try it before you reveal the answer, then read why each choice is right or wrong.

WebXam-style domain: Bio-Molecular TechnologySelf-check skill: Comparing viral vectors by integration and insertion risk
A gene therapy team wants a vector with low immune response that does not insert itself into the patient's genome, to reduce insertion-mutation risk. Which vector best fits?

Tap an answer to see the full explanation. Nothing is recorded or graded.